ArticleAlpha psychiatry2026
Disrupted Functional Brain Network Topology in Etomidate Misuse.
Article in Alpha psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Etomidate misuse (EM) has recently become an increasing public health concern in East and Southeast Asia, but its neurobiological mechanisms are still not well understood. Although substance use disorders (SUDs) are commonly associated with disruptions in large-scale brain network organization, the effects of EM on brain network topology remain largely unexplored. Methods: Resting-state functional magnetic resonance imaging (rs-fMRI) data were acquired from individuals with EM and healthy controls (HC). Graph theoretical analyses were employed to and characterize global and nodal topological properties of functional brain networks. Clinical assessments captured substance use characteristics, craving, impulsivity, and addiction severity. Partial correlation analyses were conducted to examine associations between network metrics and substance use characteristics. Additonally, a support vector machine (SVM) classifier was implemented to discriminate individuals with EM from HC based on network features. Results: A total of 103 individuals with EM and 57 HC were included in the final analysis. Global topological organization that appeared was largely preserved in the EM group, with the exception of a significantly reduced clustering coefficient. At the nodal level, individuals with EM exhibited significant alterations in degree centrality, betweenness centrality, and nodal efficiency across regions predominantly distributed within the default mode, attention, and sensorimotor networks. Correlation analyses revealed no significant associations between network metrics and substance use characteristics following correction for multiple comparisons. Furthermore, the SVM model achieved moderate classification performance (accuracy = 66.7%) with an area under the curve (AUC) of 0.711. Conclusions: This study provides the first systematic investigation of the brain network topology in EM. The findings indicate widespread alterations in nodal network properties alongside relatively preserved global topological organization. While these results may offer preliminary indicators related to EM, their clinical relevance requires further in future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.